SE8903503L - Kombination av pseudoplastisk gel och ett partikelformat, kristallint eller frystorkat laekemedel foer parenteral administrering och ett saett att bereda en saadan kombination - Google Patents

Kombination av pseudoplastisk gel och ett partikelformat, kristallint eller frystorkat laekemedel foer parenteral administrering och ett saett att bereda en saadan kombination

Info

Publication number
SE8903503L
SE8903503L SE8903503A SE8903503A SE8903503L SE 8903503 L SE8903503 L SE 8903503L SE 8903503 A SE8903503 A SE 8903503A SE 8903503 A SE8903503 A SE 8903503A SE 8903503 L SE8903503 L SE 8903503L
Authority
SE
Sweden
Prior art keywords
combination
crystalline
prepare
particle size
way
Prior art date
Application number
SE8903503A
Other languages
Unknown language ( )
English (en)
Other versions
SE8903503D0 (sv
SE465950B (sv
Inventor
T Fjellstroem
Original Assignee
Medinvent Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinvent Sa filed Critical Medinvent Sa
Priority to SE8903503A priority Critical patent/SE465950B/sv
Publication of SE8903503D0 publication Critical patent/SE8903503D0/sv
Priority to PCT/SE1990/000683 priority patent/WO1991005544A1/en
Priority to DE1990916175 priority patent/DE497846T1/de
Priority to CA002067228A priority patent/CA2067228C/en
Priority to EP90916175A priority patent/EP0497846B1/en
Priority to DE69028710T priority patent/DE69028710T2/de
Priority to JP2514918A priority patent/JP3017801B2/ja
Priority to AT90916175T priority patent/ATE143257T1/de
Priority to AU66237/90A priority patent/AU632634B2/en
Publication of SE8903503L publication Critical patent/SE8903503L/sv
Publication of SE465950B publication Critical patent/SE465950B/sv
Priority to US08/344,707 priority patent/US5614221A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
SE8903503A 1989-10-23 1989-10-23 Kombination av ett aggregat partikelformat, kristallint eller frystorkat laekemedel med en pseudoplastisk gel foer beredning av ett injicerbart preparat samt foerfarande foer dess framstaellning SE465950B (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE8903503A SE465950B (sv) 1989-10-23 1989-10-23 Kombination av ett aggregat partikelformat, kristallint eller frystorkat laekemedel med en pseudoplastisk gel foer beredning av ett injicerbart preparat samt foerfarande foer dess framstaellning
AU66237/90A AU632634B2 (en) 1989-10-23 1990-10-22 Drug delivery system, method for preparing the same, and use thereof
EP90916175A EP0497846B1 (en) 1989-10-23 1990-10-22 Drug delivery system, method for preparing the same, and use thereof
DE1990916175 DE497846T1 (de) 1989-10-23 1990-10-22 Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung.
CA002067228A CA2067228C (en) 1989-10-23 1990-10-22 Drug delivery system, method for preparing the same and use thereof
PCT/SE1990/000683 WO1991005544A1 (en) 1989-10-23 1990-10-22 Drug delivery system, method for preparing the same, and use thereof
DE69028710T DE69028710T2 (de) 1989-10-23 1990-10-22 Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung
JP2514918A JP3017801B2 (ja) 1989-10-23 1990-10-22 薬剤デリバリーシステム、その製造方法および使用
AT90916175T ATE143257T1 (de) 1989-10-23 1990-10-22 Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung
US08/344,707 US5614221A (en) 1989-10-23 1994-11-21 Method of preparing a drug delivery system comprising a drug and a gel using a syringe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8903503A SE465950B (sv) 1989-10-23 1989-10-23 Kombination av ett aggregat partikelformat, kristallint eller frystorkat laekemedel med en pseudoplastisk gel foer beredning av ett injicerbart preparat samt foerfarande foer dess framstaellning

Publications (3)

Publication Number Publication Date
SE8903503D0 SE8903503D0 (sv) 1989-10-23
SE8903503L true SE8903503L (sv) 1991-04-24
SE465950B SE465950B (sv) 1991-11-25

Family

ID=20377242

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8903503A SE465950B (sv) 1989-10-23 1989-10-23 Kombination av ett aggregat partikelformat, kristallint eller frystorkat laekemedel med en pseudoplastisk gel foer beredning av ett injicerbart preparat samt foerfarande foer dess framstaellning

Country Status (9)

Country Link
US (1) US5614221A (sv)
EP (1) EP0497846B1 (sv)
JP (1) JP3017801B2 (sv)
AT (1) ATE143257T1 (sv)
AU (1) AU632634B2 (sv)
CA (1) CA2067228C (sv)
DE (1) DE69028710T2 (sv)
SE (1) SE465950B (sv)
WO (1) WO1991005544A1 (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2995090B2 (ja) * 1993-03-19 1999-12-27 キユー・メド・アクチエボラーグ 組織増大のための組成物および方法
US5716631A (en) * 1995-09-29 1998-02-10 Rdn Therapeutics Inc. Long acting narcotic analgesics and antagonists
CN1126537C (zh) * 1996-05-23 2003-11-05 株式会社三养社 可局部给药,可生物降解和持续释放的用于治疗牙周炎的药物组合物及其制备方法
EP0959873B1 (en) 1996-12-20 2006-03-01 ALZA Corporation Gel composition and methods
US7919109B2 (en) * 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7651703B2 (en) 1999-10-15 2010-01-26 Genentech, Inc. Injection vehicle for polymer-based formulations
US7582311B1 (en) 1999-10-15 2009-09-01 Genentech, Inc. Injection vehicle for polymer-based formulations
WO2003000282A1 (en) 2001-06-21 2003-01-03 Genentech, Inc. Sustained release formulation
EP1539193A4 (en) * 2002-07-03 2010-05-05 Pericor Science Inc HYALURONIC ACID COMPOSITIONS AND METHODS OF USE
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
FR2850282B1 (fr) 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
KR101106510B1 (ko) 2006-05-30 2012-01-20 인타르시아 세라퓨틱스 인코포레이티드 투피스, 내부채널 삼투압 전달 시스템 유동 조절기
DK2049081T3 (da) 2006-08-09 2013-02-25 Intarcia Therapeutics Inc Osmotiske leveringssystemer og stempelarrangementer
ES2402172T3 (es) 2007-04-23 2013-04-29 Intarcia Therapeutics, Inc Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
HUE043228T2 (hu) 2007-06-22 2019-08-28 Univ Texas Stabil szubmikron peptid vagy protein részecskék képzése vékonyfilm fagyasztással
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
CA2743789C (en) 2008-11-16 2017-10-31 Board Of Regents, The Univesity Of Texas System Low viscosity highly concentrated suspensions
CN107638562B (zh) 2009-09-28 2022-12-02 精达制药公司 基本稳态药物递送的快速建立和/或终止
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
BR112018073511A2 (pt) 2016-05-16 2019-03-26 Intarcia Therapeutics, Inc. polipeptídeos seletivos do receptor de glucagon e métodos de uso dos mesmos
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
MX2019008006A (es) 2017-01-03 2019-08-29 Intarcia Therapeutics Inc Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663685A (en) * 1968-04-01 1972-05-16 Minnesota Mining & Mfg Biodegradable radioactive particles
US4169804A (en) * 1976-08-19 1979-10-02 Minnesota Mining And Manufacturing Company Magnetically responsive composite microparticle
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
DE3484584D1 (de) * 1983-10-14 1991-06-20 Sumitomo Pharma Injektionen mit verzoegerter abgabe.
US4624665A (en) * 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
IT1186766B (it) * 1985-11-08 1987-12-16 Sclavo Spa Metodo per la preparazione di immunoglobuline per uso endovenoso
EP0224987B1 (en) * 1985-11-29 1992-04-15 Biomatrix, Inc. Drug delivery systems based on hyaluronan, derivatives thereof and their salts and method of producing same
JPS63624A (ja) * 1986-06-19 1988-01-05 Nec Corp 正規乱数発生方法
DE3626868A1 (de) * 1986-08-08 1988-02-11 Bayer Ag Parenterale loesung

Also Published As

Publication number Publication date
SE8903503D0 (sv) 1989-10-23
SE465950B (sv) 1991-11-25
DE69028710D1 (de) 1996-10-31
EP0497846B1 (en) 1996-09-25
JPH05503921A (ja) 1993-06-24
AU632634B2 (en) 1993-01-07
US5614221A (en) 1997-03-25
DE69028710T2 (de) 1997-04-17
JP3017801B2 (ja) 2000-03-13
CA2067228A1 (en) 1991-04-24
CA2067228C (en) 2002-01-08
AU6623790A (en) 1991-05-16
WO1991005544A1 (en) 1991-05-02
ATE143257T1 (de) 1996-10-15
EP0497846A1 (en) 1992-08-12

Similar Documents

Publication Publication Date Title
SE8903503D0 (sv) Kombination av pseudoplastisk gel och ett partikelformat, kristallint eller frystorkat laekemedel foer parenteral administrering och ett saett att bereda en saadan kombination
Ettinghausen et al. Recombinant interleukin 2 stimulates in vivo proliferation of adoptively transferred lymphokine-activated killer (LAK) cells.
US5783214A (en) Bio-erodible matrix for the controlled release of medicinals
RU2242969C2 (ru) Быстро диспергируемые лекарственные формы, содержащие рыбий желатин
US4855134A (en) Sustained-release preparation
ATE116844T1 (de) Verschiedenartige zelluloseether enthaltende, oral verabreichbare arzneimittelformen mit gesteuerter wirkstofffreigabe.
EP0139286A2 (en) Prolonged sustained-release preparations
NZ501950A (en) Medicinal compositions for application to mucosa
KR880001297A (ko) 과립구 콜로니 자극인자를 함유하는 안정한 약제 및 그의 제조방법
DE60044261D1 (de) Verfahern zur herstellung von festen verabreichungssystemen für eingekapselte und nicht-eingekapselte pharmazeutische wirkstoffe
ES488168A0 (es) Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
US3911098A (en) Medicament carrier
ATE235889T1 (de) Mikropartikel aus chitosan-gelatin a
JP2004256549A (ja) 凍結乾燥バイオマトリックス
JPS61165337A (ja) 熱成形可能な徐放性マトリツクス
DK0460020T3 (da) Medikamentleveringssammensætninger
KR960703019A (ko) 친수성-흡습성 중합체로부터의 건조된 하이드로겔(Dried hydrogel from hydrophylic-hygroscopic polymer)
PT97369A (pt) Processo para a preparacao de formulacoes farmaceutica na qual o sabor do medicamento e disfarcado por meio de revestimento do medicamento com uma membrana polimerica
US20030103933A1 (en) Proteins stabilized with polysaccharide gums
NL8601285A (nl) Farmaceutische preparaten voor nasale toediening.
SE9704401D0 (sv) Matrix pellets for greasy, oily or sticky drug substances
JP2023513742A (ja) 天然ポリマーベースのパッチ製品
GB1412970A (en) Pharmaceutical preparations containing silicone rubber
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
JPH07507303A (ja) 非イオン系セルロースエーテル誘導体およびキチン由来の重合体を含む医薬用粉末組成物

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8903503-4

Format of ref document f/p: F

NUG Patent has lapsed